Valentina Tabanelli

Medicine & Life Sciences

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Dendritic Cells 82%
3. B-Cell Lymphoma 61%
4. Peripheral T-Cell Lymphoma 54%
5. Neoplasms 50%
6. venetoclax 49%
7. Genomics 40%
8. Epigenomics 36%
9. Gene Expression Profiling 30%
10. Whole Exome Sequencing 28%
11. Anaplastic Large-Cell Lymphoma 26%
12. Therapeutics 22%
13. Cellular Microenvironment 21%
14. Follicular Dendritic Cell Sarcoma 19%
15. B-Lymphocytes 19%
16. Genes 18%
17. Lymphoma 18%
18. Hematologic Neoplasms 17%
19. B7-H1 Antigen 16%
20. Survival 15%
21. Regulatory B-Lymphocytes 14%
22. Myeloid Sarcoma 14%
23. Breast Implants 14%
24. Gene Expression 13%
25. Tumor Escape 13%
26. Drug Therapy 13%
27. Liver X Receptors 13%
28. Histiocytes 11%
29. Pathology 11%
30. Progression-Free Survival 11%
31. Cell Line 11%
32. Rituximab 10%
33. B-Lymphocyte Subsets 10%
34. Hematology 10%
35. Non-Hodgkin's Lymphoma 10%
36. Data Analysis 10%
37. Dissection 10%
38. Decitabine 10%
39. Hodgkin Disease 10%
40. Breast 10%
41. Tumor Microenvironment 9%
42. Human Herpesvirus 4 9%
43. Tumor Suppressor Genes 9%
44. Natural Language Processing 9%
45. Formaldehyde 9%
46. Paraffin 9%
47. Hepacivirus 9%
48. Chromatin Immunoprecipitation Sequencing 8%
49. T-Lymphocytes 8%
50. DNA Damage 8%